Ethambutol toxic optic neuropathy: A case report and review

African Vision and Eye Health

 
 
Field Value
 
Title Ethambutol toxic optic neuropathy: A case report and review
 
Creator Phillips, Kevin C. Clarke-Farr, Peter C.
 
Subject optometry; primary care Ethambutol; toxic optic neuropathy; tuberculosis; drug toxicity; central field defect
Description This article presents a case of ethambutol toxic optic neuropathy determined during the routine optometric examination of a 66-year-old man. Ethambutol is an established drug for the treatment of tuberculosis, but has significant side effects, notably optic neuropathy. The prognosis for vision restoration is unpredictable, with the possibility of permanent vision loss. Treatment cessation is the only option to limit ocular damage; therefore, the early recognition of ethambutol optic neuropathy by optometrists is essential.
 
Publisher AOSIS
 
Contributor
Date 2018-05-17
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Case Report and review
Format text/html application/epub+zip application/xml application/pdf
Identifier 10.4102/aveh.v77i1.419
 
Source African Vision and Eye Health; Vol 77, No 1 (2018); 3 pages 2410-1516 2413-3183
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://avehjournal.org/index.php/aveh/article/view/419/817 https://avehjournal.org/index.php/aveh/article/view/419/816 https://avehjournal.org/index.php/aveh/article/view/419/818 https://avehjournal.org/index.php/aveh/article/view/419/815
 
Coverage Africa; South Africa; Western Cape 2017 Tuberculosis patients
Rights Copyright (c) 2018 Kevin C. Phillips, Peter C. Clarke-Farr https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT